27 January 2014

Nigeria: Rivers Syringe Factory Almost Complete

Abuja — THE syringes production factory site in Port Harcourt is poised to provide employment to 2 000 people in the Rivers State, Commissioner for Health, Dr Tamunoiyoriari Parker, said.

Parker disclosed that the facility was now 70 percent complete.

The 2 000 people would be directly employed when the project is eventually completed.

Parker stressed that the factory which is WHO certified is expected to produce about one billion syringes, hypodermic needles and other pharmaceuticals such as IV giving sets, eye, ear and nose drops, IV fluids and injectibles that will be adjunct to the factory.

“The Government has the plans to produce vaccines in the integrated medical industries. We want to leave for the Rivers People an industry that is second to none in Africa and to compete with the rest of the world,” the commissioner said.

This past weekend, Parker toured the ongoing expansion project.

He said the present administration was poised to deliver on its promises to the Rivers People before the end of its tenure and stated that no amount of “political distraction” could make it lose its focus to deliver.

Copyright © 2014 CAJ News Agency. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 2,000 reports a day from more than 130 news organizations and over 200 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.